e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Surgical management of thoracic infections and issues in respiratory physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumonectomy for destroyed lung – clinical and therapeutical assesements
N. Galie, E. Crisan, E. Tabacu, B. Coman, C. Marica, V. Grigorie (Bucharest, Romania)
Source:
Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Session:
Surgical management of thoracic infections and issues in respiratory physiology
Session type:
Thematic Poster Session
Number:
3790
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Galie, E. Crisan, E. Tabacu, B. Coman, C. Marica, V. Grigorie (Bucharest, Romania). Pneumonectomy for destroyed lung – clinical and therapeutical assesements. Eur Respir J 2007; 30: Suppl. 51, 3790
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 172s
Year: 2004
Pneumonectomy in children for destroyed lung: long-term outcomes
Source: Eur Respir J 2005; 26: Suppl. 49, 631s
Year: 2005
Does surgical lung biopsy change the diagnosis and treatment in interstitial lung diseases?
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease?
Source: Eur Respir J 2007; 29: 1064
Year: 2007
The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007
Therapeutic pneumothorax in the treatment of cavitary lung TB: a renaissance of collapsotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004
Complications and mortality of tranbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Surgical lung biopsies for diagnosis of interstitial lung disease
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003
Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The surgical treatment of lung bronchiectasis.
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse lung disease
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Surgical management for lung aspergillosis
Source: Eur Respir J 2003; 22: Suppl. 45, 324s
Year: 2003
Outcomes of pulmonary rehabilitation after lung resection in patients with lung cancer
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
Source: Eur Respir J, 53 (2) 1801164; 10.1183/13993003.01164-2018
Year: 2019
Complex treatment of widespread destructive pulmonary tuberculosis using innovative technology of the main bronchial stump treatment during pneumonectomy
Source: Virtual Congress 2021 – Rare thoracic surgical disease and the chest wall
Year: 2021
Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management?
Source: Breathe 2008; 4: 233-239
Year: 2008
Is transbronchial lung biopsy using cryoprobes useful in the management of diffuse lung disease?
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013
Diagnostic yield of surgical lung biopsy in immunocompromised patients with pulmonary infiltrates
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept